Expression of NK cell markers
. | WT, % . | Plcg2–/–, % . |
|---|---|---|
| CD16 | 99 ± 1 | 99 ± 1 |
| CD244 | 99 ± 1 | 99 ± 1 |
| CD69 | 29 ± 8 | 34 ± 24 |
| Ly49A | 2 ± 1 | 2 ± 1 |
| Ly49C/I | 31 ± 11 | 9 ± 5* |
| Ly49D | 13 ± 7 | 7 ± 3* |
| Ly49G2 | 41 ± 5 | 5 ± 1* |
| Ly49H+C/I– | 31 ± 9 | 29 ± 4 |
| NK1.1 | 99 ± 1 | 99 ± 1 |
| NKG2A/C/E | 76 ± 6 | 64 ± 5* |
. | WT, % . | Plcg2–/–, % . |
|---|---|---|
| CD16 | 99 ± 1 | 99 ± 1 |
| CD244 | 99 ± 1 | 99 ± 1 |
| CD69 | 29 ± 8 | 34 ± 24 |
| Ly49A | 2 ± 1 | 2 ± 1 |
| Ly49C/I | 31 ± 11 | 9 ± 5* |
| Ly49D | 13 ± 7 | 7 ± 3* |
| Ly49G2 | 41 ± 5 | 5 ± 1* |
| Ly49H+C/I– | 31 ± 9 | 29 ± 4 |
| NK1.1 | 99 ± 1 | 99 ± 1 |
| NKG2A/C/E | 76 ± 6 | 64 ± 5* |
Percent of cells expressing the indicated markers on gated CD3–NK1.1+ cells from spleens of individual hematopoietic chimeras 4 to 7 weeks after reconstitution with WT or Plcg2–/– fetal liver cells (6-9 mice/group were analyzed).
P < .05